We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Prologis
PLD
$121B
| $3.16M | 0.06% |
24,720
| – | – |
2024 Q4
5 quarters
|
|
252
iShares MSCI EAFE Growth ETF
EFG
$15B
| $3.13M | 0.06% |
27,482
| – | – |
2025 Q2
3 quarters
|
|
253
Charles Schwab
SCHW
$160B
| $3.11M | 0.06% |
31,083
| – | – |
2023 Q4
9 quarters
|
|
254
Invesco NASDAQ 100 ETF
QQQM
$107B
| $3.09M | 0.06% |
12,211
| – | – |
2025 Q3
2 quarters
|
|
255
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $3.08M | 0.06% |
39,779
| – | – |
2022 Q2
15 quarters
|
|
256
Boston Scientific
BSX
$63.7B
| $3.01M | 0.06% |
31,618
| – | – |
2024 Q1
8 quarters
|
|
257
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.89B
| $2.97M | 0.06% |
132,595
| – | – |
2022 Q1
16 quarters
|
|
258
Barclays
BCS
$76.6B
| $2.97M | 0.06% |
116,657
| – | – |
2022 Q1
16 quarters
|
|
259
Stryker
SYK
$113B
| $2.95M | 0.06% |
8,407
| – | – |
2024 Q2
7 quarters
|
|
260
iShares Russell 3000 ETF
IWV
$20.3B
| $2.93M | 0.06% |
7,581
| – | – |
2024 Q4
5 quarters
|
|
261
AerCap
AER
$23B
| $2.93M | 0.06% |
20,384
| – | – |
2024 Q3
6 quarters
|
|
262
Amphenol
APH
$198B
| $2.93M | 0.06% |
43,356
| – | – |
2024 Q3
6 quarters
|
|
263
Analog Devices
ADI
$197B
| $2.93M | 0.06% |
10,797
| – | – |
2024 Q2
7 quarters
|
|
264
Deere & Co
DE
$173B
| $2.92M | 0.06% |
6,265
| – | – |
2022 Q2
15 quarters
|
|
265
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $2.92M | 0.06% |
36,994
| – | – |
2025 Q3
2 quarters
|
|
266
JPMorgan Diversified Return US Equity ETF
JPUS
$460M
| $2.91M | 0.06% |
23,509
| – | – |
2024 Q4
5 quarters
|
|
267
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $2.91M | 0.06% |
116,159
| – | – |
2022 Q2
15 quarters
|
|
268
Hartford Financial Services
HIG
$36.3B
| $2.86M | 0.06% |
20,751
| – | – |
2024 Q3
6 quarters
|
|
269
Autodesk
ADSK
$50.1B
| $2.86M | 0.06% |
9,660
| – | – |
2022 Q2
15 quarters
|
|
270
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $2.85M | 0.06% |
56,253
| – | – |
2024 Q4
5 quarters
|
|
271
Elevance Health
ELV
$92.9B
| $2.84M | 0.06% |
8,088
| – | – |
2022 Q1
16 quarters
|
|
272
Royal Caribbean
RCL
$76B
| $2.83M | 0.06% |
10,146
| – | – |
2024 Q3
6 quarters
|
|
273
iShares MSCI Intl Value Factor ETF
IVLU
$4.49B
| $2.83M | 0.06% |
74,368
| – | – |
2025 Q2
3 quarters
|
|
274
Schwab US Dividend Equity ETF
SCHD
$115B
| $2.81M | 0.06% |
102,454
| – | – |
2025 Q2
3 quarters
|
|
275
First Horizon
FHN
$10.9B
| $2.8M | 0.06% |
117,328
| – | – |
2024 Q4
5 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.